Review
doi: 10.1007/978-3-540-71029-5_11.
Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs
Affiliations
- PMID: 19031029
- DOI: 10.1007/978-3-540-71029-5_11
Item in Clipboard
Review
Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs
Handb Exp Pharmacol.
2009.
Abstract
Dendritic cells (DCs) have a central role in immune regulation, ranging from tolerance induction to the induction of specific immune responses. DCs serve as an essential link between innate and adaptive immunity. This broad range of powerful immune stimulatory as well as regulatory functions has made DCs as targets for vaccine development strategies. One approach to promote the tolerogenicity of DCs is to suppress their maturation by pharmacological agents, including glucocorticoids (GCs). In the present chapter we will review GCs used in vitro with cultured DCs, applied in vivo, or used to generate tolerogenic DCs for cellular therapy.
Similar articles
-
Induction of tolerogenic dendritic cells by vitamin D receptor agonists.Handb Exp Pharmacol. 2009;(188):251-73. doi: 10.1007/978-3-540-71029-5_12. Handb Exp Pharmacol. 2009. PMID: 19031030 Review.
-
In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy.Methods Mol Biol. 2011;677:149-59. doi: 10.1007/978-1-60761-869-0_10. Methods Mol Biol. 2011. PMID: 20941608
-
The regulatory role of dendritic cells in the immune tolerance.Biomed Mater Eng. 2006;16(4 Suppl):S163-70. Biomed Mater Eng. 2006. PMID: 16823108 Review.
-
Aspirin and the induction of tolerance by dendritic cells.Handb Exp Pharmacol. 2009;(188):197-213. doi: 10.1007/978-3-540-71029-5_9. Handb Exp Pharmacol. 2009. PMID: 19031027 Review.
-
Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.Curr Opin Organ Transplant. 2008 Aug;13(4):350-7. doi: 10.1097/MOT.0b013e328306116c. Curr Opin Organ Transplant. 2008. PMID: 18685329 Review.
Cited by
-
Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine.Mol Pharm. 2013 Jun 3;10(6):2199-210. doi: 10.1021/mp300350e. Epub 2012 Nov 29. Mol Pharm. 2013. PMID: 23194373 Free PMC article.
-
Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells.Med Sci Monit. 2011 May;17(5):BR125-31. doi: 10.12659/msm.881758. Med Sci Monit. 2011. PMID: 21525800 Free PMC article.
-
Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.Inflammopharmacology. 2020 Feb;28(1):311-319. doi: 10.1007/s10787-019-00641-1. Epub 2019 Sep 24. Inflammopharmacology. 2020. PMID: 31552546
-
NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.Oncotarget. 2015 Jun 10;6(16):14123-38. doi: 10.18632/oncotarget.4234. Oncotarget. 2015. PMID: 26053099 Free PMC article.
-
Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro.PLoS One. 2009 Aug 14;4(8):e6645. doi: 10.1371/journal.pone.0006645. PLoS One. 2009. PMID: 19680551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
